Drug details:
Molecular formula: C₂₂H₁₉N₃O₄S₃

Standard name: (E)-N-(6-methylsulfonyl-1,3-benzothiazol-2-yl)-3-[3-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]prop-2-enamide

Curated SMILES: CC1=NC(COC2=CC(/C=C/C(=O)NC3=NC4=C(C=C(S(C)(=O)=O)C=C4)S3)=CC=C2)=CS1

Evidence for compound's anti-virulence activity:

Shigella
Related VF: TTSS (Type III secretion system)
Target: Spa47
Drug effect: Inhibits T3SS ATPase.
Max phase: Preclinical (in vitro)
Publication:
Case HB, et al., 2018. Shutting Down Shigella Secretion: Characterizing Small Molecule Type Three Secretion System ATPase Inhibitors. Biochemistry 57(50):6906-6916.